Elahe Minaei focuses on localised immunotherapies to treat pancreatic cancer.

A University of Wollongong (UOW) PhD candidate who is using revolutionary immunotherapies to target pancreatic cancer has been named the recipient of a global Rising Researcher Award.

Elahe Minaei, who is in the third year of a PhD in Associate Professor Kara Vine-Perrow’s Targeted Cancer Therapeutics Research Laboratory at Molecular Horizons, is the Australian winner of the competition run by Promega, a biotechnology company based in the United States. Elahe, who was chosen from five Australian finalists, is one of 10 winners drawn from countries around the world, including Brazil, Belgium, Finland, and Italy.

Want to apply to The University of Wollongong? Contact ACIC now!